A 68-year-old man presents with lower urinary tract symptoms of hesitancy, weak stream and nocturia. Digital rectal examination reveals a smooth, enlarged prostate. PSA is within age-specific range. According to Australian guidelines, what is the most appropriate first-line pharmacological management for symptomatic benign prostatic hyperplasia?